Skip to main content
SpringerLink
Log in

Aldosteron-Antagonisten zur Prävention des Fortschreitens der chronischen Niereninsuffizienz

Aldosterone antagonists for preventing the progression of chronic kidney disease

  • Evidenzbasierte Medizin
  • Published:
Der Urologe Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351(13):1296–1305

    Article  CAS  PubMed  Google Scholar 

  2. http://leitlinien.dgk.org/files/2006_Empfehlungen_koronare_Herzkrankheit_Niereninsuffizienz_Teil_1.pdf. Zugegriffen: 1. Aug. 2016

  3. Coresh J, Selvin E, Stevens LA et al (2007) Prevalence of chronic kidney disease in the United States. JAMA 298(17):2038–2047

    Article  CAS  PubMed  Google Scholar 

  4. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW et al (1994) The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330(13):877–884

    Article  CAS  PubMed  Google Scholar 

  5. Brenner BM (2003) Retarding the progression of renal disease. Kidney Int 64(1):370–378

    Article  PubMed  Google Scholar 

  6. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH et al (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345(12):861–869

    Article  CAS  PubMed  Google Scholar 

  7. Mathiesen ER, Hommel E, Hansen HP, Smidt UM, Parving HH (1999) Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria. BMJ 319(7201):24–25

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G et al (2001) Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med 135(2):73–87

    Article  CAS  PubMed  Google Scholar 

  9. Strippoli GF, Bonifati C, Craig M, Navaneethan SD, Craig JC (2006) Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease. Cochrane Database Syst Rev 4:Cd006257

    PubMed  Google Scholar 

  10. Fritsch Neves M, Schiffrin EL (2003) Aldosterone: a risk factor for vascular disease. Curr Hypertens Rep 5(1):59–65

    Article  PubMed  Google Scholar 

Download references

Danksagung

UroEvidence dankt Ingrid Töws (Cochrane Deutschland) für die Durchsicht und Kommentare zu dieser Übersetzung.

Author information

Authors and Affiliations

  1. DGU-Hauptstadtbüro Berlin, Deutsche Gesellschaft für Urologie e.V., Kuno-Fischer-Str. 8, 14057, Berlin, Deutschland

    S. Schmidt

  2. Urologische Klinik, Klinikum der Universität München, Großhadern, Marchioninistr. 15, 81377, München, Deutschland

    A. Spek

Authors
  1. S. Schmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Spek
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Schmidt.

Ethics declarations

Interessenkonflikt

S. Schmidt und A. Spek geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schmidt, S., Spek, A. Aldosteron-Antagonisten zur Prävention des Fortschreitens der chronischen Niereninsuffizienz. Urologe 55, 1360–1363 (2016). https://doi.org/10.1007/s00120-016-0215-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-016-0215-1

Search

Navigation